Arvind Rajpal
Bristol-Myers Squibb (Germany)(DE)Pfizer (United States)(US)Bristol-Myers Squibb (United States)(US)Fate Therapeutics (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, Multiple Myeloma Research and Treatments, HER2/EGFR in Cancer Research
Most-Cited Works
- → Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates(2013)488 cited
- → Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire(2009)441 cited
- → VISTA is an acidic pH-selective ligand for PSGL-1(2019)381 cited
- → Human Responses to Influenza Vaccination Show Seroconversion Signatures and Convergent Antibody Rearrangements(2014)261 cited
- → Designing antibodies as therapeutics(2022)243 cited
- → Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design(2016)201 cited